http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28899717

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 2317
issn 1538-7445
0008-5472
issueIdentifier 6
pageRange 2308-2317
publicationName Cancer Research
startingPage 2308
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_da0af5395402d65b10a72469022b9eb2
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_631cf9b9ee79731b6b3485771b1e91f6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63127e2fc050f162b39c676f348147a9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6573580ed36620d40642a8cc539caeed
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_62590e6028615744a54e76f45bbc2657
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9e7c1a296cf1f4e98050332cef587775
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1045a7fd05193c69c2909f85369be068
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d694531b1ce166f7c7fe720cb36c59e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bc2e92bcbf6816343883637557672eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d74abf10c0c1b4c354bc92f52354cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_88485a835728fedf518dffa816175173
bibliographicCitation Goellner EM, Grimme B, Brown AR, Lin YC, Wang XH, Sugrue KF, Mitchell L, Trivedi RN, Tang JB, Sobol RW. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 2011 Mar 15;71(6):2308–17. PMID: 21406402; PMCID: PMC3077901.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ab40f84759ffd503aad5f2e8ecd46e2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e34b21667662fc0d858849abde6e64a8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_595f4fd41b829e9eb69b6290891e7c97
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de07f6e398be229f2ba2525e956c6530
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ef7d08efca29400db9910042b168d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48e3eb94eebd927f0f30052acf050320
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea4b2a9cdac193d9f14bd371145ad340
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_585205f80a665e1536cea5d4ffceccba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_349025c06d9e0bda1a68406b0e9c4f51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9bf67deb55e40226897a07b804bc132
date 2011-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21406402
https://pubmed.ncbi.nlm.nih.gov/PMC3077901
https://doi.org/10.1158/0008-5472.can-10-3213
isPartOf https://portal.issn.org/resource/ISSN/1538-7445
https://portal.issn.org/resource/ISSN/0008-5472
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
discusses http://id.nlm.nih.gov/mesh/M0136562
http://id.nlm.nih.gov/mesh/M0010767
http://id.nlm.nih.gov/mesh/M0000395
http://id.nlm.nih.gov/mesh/M0073348
http://id.nlm.nih.gov/mesh/M0028268
http://id.nlm.nih.gov/mesh/M0017141
http://id.nlm.nih.gov/mesh/M0013613
http://id.nlm.nih.gov/mesh/M0459005
http://id.nlm.nih.gov/mesh/M0000268
http://id.nlm.nih.gov/mesh/M0005636
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0046591
http://id.nlm.nih.gov/mesh/M0014403
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009243Q000096
http://id.nlm.nih.gov/mesh/D019008Q000187
http://id.nlm.nih.gov/mesh/D004260Q000187
http://id.nlm.nih.gov/mesh/D003606Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D045647Q000235
http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D008741Q000494
http://id.nlm.nih.gov/mesh/D000255Q000378
http://id.nlm.nih.gov/mesh/D000077204
http://id.nlm.nih.gov/mesh/D045647Q000378
http://id.nlm.nih.gov/mesh/D006898Q000494
http://id.nlm.nih.gov/mesh/D034622
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003606Q000494
http://id.nlm.nih.gov/mesh/D000178Q000494
http://id.nlm.nih.gov/mesh/D005909Q000473
http://id.nlm.nih.gov/mesh/D005909Q000235
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D005909Q000378
http://id.nlm.nih.gov/mesh/D010880Q000494
http://id.nlm.nih.gov/mesh/D011065Q000235
http://id.nlm.nih.gov/mesh/D004305
http://id.nlm.nih.gov/mesh/D018906Q000494
http://id.nlm.nih.gov/mesh/D015151
http://id.nlm.nih.gov/mesh/D011065Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.37
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.4.2.30
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15938971
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73415790

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127975509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127923535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128414420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128569758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129915080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127891409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723

Total number of triples: 105.